Kazia Therapeutics
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Three International Twrs, L 24 300 Baran...Phone Number
+61 294724101Website
www.kaziatherapeutics.comRevenue
<$5 MillionStock Symbol
KZIAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Kazia Therapeutics
Kazia Therapeutics Limited is an oncology-focused drug development company, based in Sydney, Australia.Explore more
Kazia Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kazia Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Kazia Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Kazia Therapeutics launches new products
Funding: Get notified immidiatlly once Kazia Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Kazia Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Kazia Therapeutics is spiking on competitors!
Check if Kazia Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Kazia Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Kazia Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Kazia Therapeutics
Compare insights from companies similar to Kazia Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kazia Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kazia Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kazia Therapeutics.
Kazia Therapeutics financials insights
Gather financial insights about Kazia Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$2.1M
Kazia Therapeutics Tech Stack
A closer look at the technologies used by Kazia Therapeutics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Project
Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Executive Move
Board of Directors
Kazia Therapeutics News & Media
Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and Produces Statistically Significant Antitumor Activity Three-Arm Expansion of the Ongoing TNBC Trial Will Evaluate Paxalisib Plus Fulvestrant, With Palbociclib, Versus Standard-of-Care First...Kazia (NASDAQ: KZIA) raises cash for cancer drug as share count nears 10B - Stock Titan
Share count could jump to about 9.9B if all new warrants are exercised, as Kazia uses a ~$40M ADS deal to fund paxalisib trials amid going-concern warnings.Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today...Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced the pricing of its previously announced tranched registered public offering (the "Offering") of (i) 2,580,000 American Depositary Shares ("ADSs"), each representing five hundred (500) ordinary shares of the
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Kazia Therapeutics
Sign Up For FreeTo access detailed company insights
Kazia Therapeutics Limited is an oncology-focused drug development company, based in Sydney, Australia.... Read More
